NCIC CTG IND 113: two phase I dose escalation pharmacokinetic (PK) studies of BAY 12-9566 (BAY) in combination with either doxorubicin (DOX) or modulated 5-fluorouracil (FU) Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Hirte, Holger
  • Stewart, D
  • Goel, R
  • Chouinard, E
  • Huan, S
  • Elias, I
  • Matthews, S
  • Seymour, L

publication date

  • September 1999